AI data asset · anonymous listing
#2841
- Potential data value
- Assessment available after diligence
- Licensing readiness
- RESTRICTED
- Preferred structure
- Exclusive-by-category, de-identified derivatives only
Seller identity is never disclosed at this stage. Introduction requires buyer qualification, seller approval and executed confidentiality.
- Industry
- Healthcare
- Region
- United States
- Company size
- 500–2,000 employees
- Years operating
- 19+
- Historical data
- 11 years
- Estimated records
- 2.4M+ encounter and claim records
- ERP
- Workday
- CRM
- Salesforce
- Approx. employees
- 1,250
- Clinical Operations
- Claims
- Invoices
- Support Tickets
- Financial Records
- Eligibility and prior authorisation
- Coding and charge capture
- Denial triage and appeal
- Patient billing escalation
Cross-system connectivity
Epic → Workday → Salesforce
Volume
Millions of encounter-linked claim events.
96
weight 12
Historical depth
Eleven continuous years including payer-policy shifts.
94
weight 12
Workflow complexity
Denial and appeal loops with multi-role handoffs.
90
weight 12
Cross-system connectivity
Clinical-to-finance joins require deterministic keys not yet mapped.
68
weight 11
Uniqueness
Denial-resolution behaviour is rarely available at this depth.
93
weight 10
Data quality
Structured coding fields are highly complete.
88
weight 9
Outcome labels
Paid, denied, appealed and overturned outcomes all present.
92
weight 9
Industry value
Revenue-cycle automation is among the most funded agent categories.
95
weight 8
AI-agent relevance
Well suited to long-running, policy-constrained agents.
88
weight 8
Licensing readiness
PHI handling requires a covered-entity pathway before any license.
25
weight 5
Privacy / de-identification complexity
Expert-determination de-identification likely required.
22
weight 4
Why this asset scored 74
Volume, depth and outcome labelling are exceptional, and denial-resolution behaviour of this kind is genuinely scarce. The composite score is materially reduced by privacy and licensing complexity: protected health information means any evaluation must run through a covered-entity pathway with formal de-identification before a sample can leave the environment. Buyers should expect a longer diligence cycle here than the score alone suggests.
- •Revenue-cycle agents
- •Claims adjudication agents
- •Evaluation benchmarks
Ownership
Provider-generated operational records.
Source systems
Epic, Workday, Salesforce.
Third-party data
Payer correspondence embedded in workflow.
Customer / client data
Patient records; PHI in scope.
Employee data
Coder and biller identities in audit trails.
Potential PII
Direct identifiers present throughout.
Contract restrictions
Payer contracts include confidentiality terms.
Licensing permissions
Requires de-identification determination.
Retention period
Eleven years under regulatory retention.
Geographic restrictions
US processing only.
Intended AI use
Seller excludes any patient-facing model use.
De-identification requirements
Expert determination required before sample.
Status indicators reflect seller-reported information and SentryRights screening only. No asset is represented as legally licensable until rights and privacy diligence is completed with the seller and, where applicable, its counsel.
Demo data — illustrative sample listings, not live marketplace records
- Volume
- HIGH
- Historical depth
- HIGH
- Workflow complexity
- HIGH
- Cross-system connectivity
- MODERATE
- Industry uniqueness
- HIGH
- Data quality
- HIGH
- Outcome labels
- HIGH
- PII risk
- HIGH
- De-identification difficulty
- HIGH
- Licensing readiness
- RESTRICTED
- 1
Buyer submits request
Identity, funding stage and entity are verified before the request moves.
- 2
Buyer provides intended use
Specific model, application and downstream distribution limits stated in writing.
- 3
Platform reviews buyer
SentryRights qualifies the buyer and screens the intended use against seller preferences.
- 4
Seller receives request
Seller sees the buyer profile and intended use while remaining anonymous.
- 5
Seller approves or declines
No identity is disclosed without an explicit seller approval.
- 6
NDA / confidentiality
Mutual confidentiality executed through the platform.
- 7
Identity revealed
Counterparties are introduced only at this point.
- 8
Data diligence begins
Rights review, privacy review and de-identification are coordinated by SentryRights.